Diabetes treatment is constantly advancing, with new therapeutic options emerging to improve patient outcomes. Recent studies have focused on GLP-1 and GIP receptor agonists, a class of drugs that mimic the actions of https://marleyaano526010.liberty-blog.com/39281639/promising-glp-1-and-gip-receptor-agonists-a-new-era-in-diabetes-treatment